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tral PS was roughly half that of the charged membranes.Filtration of native and glycated 2-microglobulin by charged
Neutralizing surface electronegativity of the AN69 membraneand neutral dialysis membranes.
with PEI did not alter its binding capacity. These results suggestBackground. It has been postulated that protein glycation
that it would be useful for dialysis protocols to include compar-and formation of advanced glycation end products (AGE) are
ative studies of both serum native and modified 2m in orderamong toxic factors in chronic uremia, whether the renal dis-
to prevent 2m-amyloidosis.ease is of diabetic or nondiabetic origin. In this setting, AGE-
modified 2-microglobulin (2m) may favor dialysis 2m-related
dialysis amyloidosis. Consequently, efficient removal of modi-
fied 2m by highly permeable dialysis membranes is as impor- Chronic renal failure induces the production of varioustant as removal of native 2m to postpone the development of compounds that may have toxic effects [1]. The pathogenicdialysis amyloidosis.
role of these compounds in metabolic and structuralMethods. To define the role of dialysis membrane surface
electronegativity on plasma protein transfer, an in vitro model changes leading to many disorders, such as dialysis-related
was used to test the interactions of native and glycated2m with amyloidosis, encountered in long-term hemodialyzed pa-
various highly permeable dialysis membranes. An experimental tients is postulated. Recent biochemical and clinical stud-
circuit with minidialyzers was used. The neutral high-flux polysul-
ies have suggested that modified 2-microglobulin (2m)fone membrane (PS), the electronegative polymethylmetacryl-
favors polymerization of the protein and induces amyloidate membrane (PMMA), the electronegative AN69 membrane
and a modified AN69 membrane, the surface of which was neu- deposits [2]. Critical biotransformation of 2m is associ-
tralized with polyethyleneimine (AN69-PEI), were tested using ated with the serum increase of its main acidic isoform
both native 2m and the more acidic glycated 2m. Protein with pI 5.1, while the native form has a pI of 5.7. More
mass transfer and binding to the membrane were measured.
precisely, the acidic isoforms of 2m, which represent aResults. Mass transfer of glycated 2m was significantly de-
few percent of total serum 2m, in addition to variouscreased through all membranes tested when compared with na-
tive 2m. This result was due to the increased molecular weight breakdown fragments, contain several 2 adducts due to
of 2m, which became less permeable to porous membranes, oxidation and advanced glycation end products (AGE)
whereas adsorption of both native and glycated 2m to mem- [3–5]. AGEs have been extensively studied and are in-
branes, due to ionic interactions, decreased similarly with AN69
creased in patients with diabetes mellitus as well as pa-and AN69-PEI, but remained unchanged with PS and PMMA.
tients with end-stage renal failure not associated withMoreover, surface neutralization of AN69 membrane did not
alter its core binding capacity, since 2m absorption accounted diabetes and in the older population (abstract; Miyata
for 98 and 97% and glycated 2m for 83.7 and 81.4% of the T et al, J Am Soc Nephrol 6:552, 1995) [6–12].
protein removed with AN69 and AN69-PEI, respectively. Removal of 2m, including AGE-modified 2m, usingConclusion. Clearance of glycated 2m through highly per- highly permeable membranes, has been documentedmeable neutral and negatively charged membranes was lower
[13–15]. The constant use of highly permeable syntheticthan that of native 2m, reflecting a decreased sieving coeffi-
cient for the neoformed higher molecular weight and confor- dialysis membranes, from dialysis onset in long-term hemo-
mationally altered molecule. The binding capacity of the neu- dialyzed patients, has been shown to postpone the occur-
rence of the clinical and radiological expression of juxta-
articular bone and synovial amyloid deposits [16–18].Key words: chronic uremia, dialysis-related amyloidosis, hemodialysis,
The choice of the dialysis membrane is therefore of ma-high-flux dialysis membrane, nonenzymatic glycation, AN69 mem-
brane, polysulfone membrane, polymethylmethacrylate membrane. jor concern to limit morbidity due to 2m-related amy-
loidosis.Received for publication January 30, 2001
Several dialysis membranes are sufficiently permeableand in revised form May 3, 2001
Accepted for publication May 21, 2001 to native 2m for removing large amounts of the protein.
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slightly more efficient than hemodialysis [19]. However, pholinofructose (DMF)/mg 2m and by fluorescence
membrane performances and particularly the sieving co- measurement of AGEs [32, 33]. Fluorescence was mea-
efficient for 2m are not identical [20]. The removal of sured with a Perkin-Elmer LS50B spectrofluorometer
AGE-modified 2m has been tested by measuring the (Beaconsfield, Burks, UK) at two different ranges of
clearance of AGE-bearing proteins detected, for exam- wavelengths (exc 335 nm to em 385 nm; exc 370 nm to
ple, with anti-pentosidine or anti-carboxymethyllysine em 340 nm). Glycated 2m showed 15.9 and 6.0 times
antibodies [13, 14, 21–23]. Synthetic dialysis membranes (56.4 vs. 3.6 and 23.3 vs. 3.9 arbitrary units/mg 2m,
may be classified according to physicochemical criteria respectively) increase in fluorescence at the two sets of
that govern interactions with blood components, such as wavelengths, as well as 6.1 times increase in the content
porosity, electrical charges at the surface and in the bulk of protein-bound sugars evaluated by the nitroblue tetra-
of the membrane, and adsorption properties [24]. For zolium test (1.64 vs. 0.27 mol DMF/mg 2m). Sodium
example, the polymethylmetacrylate (PMMA) mem- dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
brane was specially designed to adsorb proteins including PAGE), Western blot analysis, and isoelectric focusing
2m in an attempt to prevent the development of dialysis showed that in vitro glycation induced the formation of
amyloidosis [25], while the AN69 membrane exhibits a higher molecular weight and more acidic forms of 2m,high adsorption capacity for C3a, C5a anaphylatoxins
as previously described [34].
[26, 27] and complement factor D [28]. The polysulfone
membrane is neutral with an in vitro zeta potential near Hemofiltration circuit
5 mV, whereas the polyacrylonitrile AN69 is negatively
The experimental model consisted of a closed circuitcharged with a potential of70 mV. For the latter mem-
with a tank containing 50 mL of the test solution and abrane, surface electronegativity accounts for activation
pump (Vial Medical VM 8000, France) flowing the solu-of the kallikrein-kinin system in the presence of citrated
tion into the minidialyzer at 10 mL/min. The test solutionplasma (pH 7.1) but not heparinized plasma (pH 7.4).
was a mixture of 49.5 mL of 4 % human albumin (wt/vol)Partial neutralization of these charges at the membrane
from healthy donors (Blood Transfusion Centre, Reims,surface using polyethyleneimine (PEI) decreases high-
France) and 50 g of glycated or nonglycated 2m in 0.5molecular-weight kininogen adsorption and the contact
mL phosphate-buffered solution. Albumin was chosenphase activation of coagulation [29, 30]. It has been ob-
as the carrier to limit 2m or glycated 2m adsorptionserved that PEI, which has a molecular weight higher than
on the circuit walls. At beginning of experiment, the105 kD, reacts at the membrane surface and does not
concentration in the tank solution was 40 mg/L for albu-penetrate into the pores of the membrane [29]. The pur-
pose of this study was to investigate in vitro the interac- min and 1 mg/L for 2m or glycated 2m. These concen-
tion of dialysis synthetic membranes that were either trations were selected to mimic normal serum values in
neutral or negatively charged with native and glycated humans. A second pump (VM 09) set at 0.2 mL/min was
2m, as a reflection of AGE-modified proteins observed used for filtrate recollection throughout the experiment.
not only in patients with diabetes mellitus but also in The 2m concentration was measured by microparticular
patients on chronic hemodialysis for non-diabetic ne- enzyme immunoassay using IMX analyzer (Abbott Diag-
phropathies. nostics, Rungis, France) in the tank solution and in the
ultrafiltrate every 15 minutes for two hours. Mass trans-
fer and adsorption on dialysis membrane were measuredMETHODS
under similar hydrodynamic conditions, taking into ac-In vitro 2m glycation
count the regular increase of protein concentration in
Five hundred micrograms of human 2m (Sigma, St. the circuit. All the samples were measured in duplicate,
Louis, MO, USA) were incubated in 0.15 mol/L phos-
and every membrane was tested five to seven times under
phate buffer, 0.02 % (m/v) sodium azide, pH 7.4, with or
similar experimental conditions.without 1 mol/L glucose (Merck, Darmstadt, Germany)
during 26 days at 37C, in sterile conditions (filtration Membranes and minidialyzers
on 0.22m Millipore filter, under laminatory flow). After
Four commercially available dialysis membranes wereincubation, the 2m solution was dialyzed overnight at
tested: polysulfone (PS, Fresenius, Germany), polyacrylo-4C against isotonic saline solution. Five hundred micro-
nitrile AN69, polyacrylonitrile AN69-PEI with reducedliter aliquots of native 2m (incubation with phosphate
surface electronegativity by polyethyleneimine (AN69-buffer alone) and glycated 2m (incubation with phos-
ST, Hospal-Cobe, France), and polymethylmetacrylatephate buffer and glucose) were stored at 20C until
(PMMA BK, Meditor, France). The hollow fiber minidi-utilization. The intensity of 2m glycation was evaluated
alyzers used in the experiments were developed as aby the alkaline reduction of nitroblue tetrazolium or
fructosamine test [31] expressed as mol of deoxymor- small scale model (1/50) of a standard hollow fiber dia-
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Table 3. Protein adsorption to membrane after aTable 1. Structural characteristics of the membranes equipping
minidialyzers used in the in vitro model of hemofiltration 120-minute in vitro session
2m Glycated 2mCharacteristic AN69 AN69-PEI PS PMMA
Membrane mg (cm2) % mg (cm2) %Effective length cm 12 12 17 15
Number of fibers 170 170 170 60
AN69 72.56.9 98.0 37.911.4b 83.7Effective surface area cm2 230 230 90 57
AN69-PEI 66.56.0 97.0 37.46.1b 81.4Zeta potential mV 705 31 51 252
PS 15.83.7c 55.1 14.25.4c 57.7
Abbreviations are: AN69, electronegative AN69 membrane; AN69-PEI, mod- PMMA 38.23.4 99.7 34.72.2 97.4
ified AN69 membrane with polyethyleneimine; PS, neutral high-flux polysulfone
Abbreviations are: AN69, electronegative AN69 membrane; AN69-PEI, mod-membrane; PMMA, polymethylmetacrylate membrane.
ified AN69 membrane with polyethyleneimine; PS, neutral high-flux polysulfone
membrane; PMMA, polymethylmetacrylate membrane.
a Indicates fraction of the protein removed by adsorption. The remaining
fraction was found in the filtrate
b P  0.05 glycated 2m vs. native 2mTable 2. Protein mass transfer
c P  0.05 PS vs. other membranes
2m Glycated 2m
Membrane lg/cm2
AN69 0.0810.032 0.0320.010a
AN69-PEI 0.0680.017 0.0280.010a
PS 0.0690.033 0.0480.014b
PMMA 0.0800.011 0.0340.004a
Abbreviations are: AN69, electronegative AN69 membrane; AN69-PEI, mod-
ified AN69 membrane with polyethyleneimine; PS, neutral high-flux polysulfone
membrane; PMMA, polymethylmetacrylate membrane.
a P  0.05 glycated 2m vs. native 2m
b P  0.05 PS vs. AN69-PEI
lyzer. The characteristics of the minidialyzers used in the
study are summarized in Table 1.
Calculated parameters
2-microglobulin mass transfer was measured in whole
ultrafiltrate. Protein binding to the membrane was calcu-
lated as the difference between 2m disappearance from
the tank and 2m recovered in the filtrate. Membrane
binding was expressed as g/cm2 of internal diameter.
Statistics
Fig. 1. Correlation between zeta potential and membrane-binding ca-
Results are expressed as mean  SD, and statistical pacity for native2m (open symbols) and glycated2m (closed symbols).
Symbols are (circles) AN69, (triangles) PMMA, and (squares) PS. Thesignificance was assessed using the Mann-Whitney U test.
AN69-PEI membrane with negative charges neutralized on the mem-
brane surface is indicated by an open (native 2m) or closed star (gly-
cated 2m).RESULTS
Mass transfer
The results obtained after 90 minutes of filtration are
Protein binding to AN69-PEI and to AN69 was similar,summarized in Table 2. 2m mass transfer was in the
indicating that neutralizing the negative charges on thesame range for the four dialysis membranes tested, and
surface of the membrane with PEI did not reduce theglycation decreased its mass transfer significantly (P 
bulk of charges acting in the core of the gel membrane.0.05) for AN69, AN69-PEI, and PMMA, respectively,
but not for PS. Protein binding to native membrane was
2m kineticscorrelated with their respective zeta potential, as shown
Using polyacrylonitrile membranes, native 2m concen-in Table 3 and Figure 1: The higher the membrane’s
tration decreased exponentially in the circuit, whereas itssurface density of negative charges, the higher its adsorp-
concentration in the filtrate increased slowly, indicatingtion of 2m whether native or glycated. In the present
2m binding to dialysis membrane up to a plateau con-experimental conditions, protein binding to the mem-
centration, which suggested a saturable process. Thebrane accounted for more than 90 % of removal of native
curves shown in Figure 2 indicate the quite similar bind-2m and 80% of glycated 2m with the exception of PS,
where it contributed to 55.1 and 57.7%, respectively. ing affinity of both the AN69 membrane and the modified
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Fig. 2. Kinetics of native 2m and glycated
2m in the circuit equipped with AN69 (A)
and AN69-PEI (B) minidialyzers. The solid
line refers to tank concentration, dotted line
to filtered protein and dashed line to adsorbed
protein.
AN69-PEI membrane. Neutralization of surface electri- DISCUSSION
cal charges by PEI slightly decreased, but not signifi- In chronically hemodialyzed patients, the use of a syn-
cantly, the adsorption of 2m on AN69, the AN69-PEI thetic, highly permeable dialysis membrane is recom-
membrane retaining the same maximal binding capacity mended to prevent the increase of2m body burden and to
lessen the formation of2m-associated amyloid deposits, aas AN69, reached after some 90 minutes. At 120 minutes
very characteristic complication of chronic uremia. Theof dialysis, approximately 80% of 2m was removed.
critical role of dialysis membrane permeability and ad-Fifty percent of the 2m removed was due to membrane
sorption in removing 2m was documented by kineticsbinding and occurred within 15 to 30 minutes of dialysis
studies using radioiodinated 2m [19]. As a consequenceonset. Polysulfone membrane exhibited a different be-
of the high sieving coefficient for 2m and better biocom-havior since its binding capacity was low; it slowly in-
patibility, highly permeable synthetic membranes post-
creased with time and reached saturation by 60 minutes pone the occurrence of clinical signs of dialysis-related
(Fig. 3). Saturation of the membrane binding capacity amyloidosis [16–18]. However, even daily hemofiltration
was reached at the 2m plateau concentration of approxi- sessions were unable to balance net 2m generation and
mately 15 to 20% of the initial tank concentration, which prevent a rise in the 2m storage pool [35, 36]. Dialysis
was four times less than that of AN69. At 120 minutes membrane interactions with plasma proteins are gov-
of dialysis, 20% of 2m was removed by adsorption. Near erned by physical forces, and among them electrical
charges play a prominent role. This role was investigated100% of native 2m was removed by membrane binding
in the present in vitro study.with the PMMA membrane, as seen in Figure 3.
Native 2m was submitted to in vitro glycation in orderGlycation of 2m decreased its binding capacity to
to induce synthesis of AGEs and then tested in minidia-both polyacrylonitrile membranes. Using ANF69, 50%
lyzers. It has already been documented that these modi-of glycated 2m was removed by adsorption at 60 min- fications increase molecular weight and render 2m moreutes. The same binding proportion was slightly deleted
acidic [9]. Membrane permeability and adsorption were
at 90 minutes with the AN69-PEI membrane. At 120 compared for both native and glycated 2m using the
minutes, 60.5 and 58.8% of glycated 2m removal re- neutral PS membrane and the electronegative AN69 and
sulted from binding to the AN69 and the AN69-PEI PMMA membranes. Protein adsorption was expressed
membrane, respectively. No gross difference was noticed as g/cm2 and not as g/cm3, since membrane thickness
between 2m and glycated 2m binding capacity for PS was not constant, precluding accurate calculation of
membrane volume.and PMMA membranes, respectively.
Randoux et al: Clearance of glycated b2 m 1575
Fig. 3. Kinetics of native 2m and glycated
2m in the circuit equipped with PS (A ) and
PMMA (B) minidialyzers. Solid line refers
to tank concentration, dotted line to filtered
protein and dashed line to adsorbed protein.
Native2m mass transfer was not significantly different significantly both the porosity and core binding capacity
of AN69 for glycated 2m.between membranes. However, 2m adsorption accounted
for more than 90% of protein removal using AN69, One of the key points for understanding the selective
removal of plasma glycated proteins by hemodialysis isAN69-PEI, or PMMA, whereas it was near 50% for PS.
Glycation of 2m decreased its mass transfer through to take into account the extreme diversity of modified
proteins resulting from the irreversible steps of the Mail-the four membranes tested. As compared with native
2m, mass transfer decrease was 47.7% with AN69 and lard reaction. Friedlander et al have studied kinetics of
early and advanced glycation end products in end-stage43.8% with AN69-PEI. In parallel, the membrane bind-
ing capacity decreased by 14.6% and 16.1%, respec- renal patients treated either by peritoneal dialysis or
intermittent hemodialysis [21, 22]. Fractionation by geltively. In contrast, glycation did not alter the 2m binding
capacity of PS. This difference may be explained by the filtration of serum proteins from patients on hemodialy-
sis revealed that one of the best studied AGEs, pentosi-electric charges acting in the bulk of AN69 membranes
as compared with the PS electroneutrality. The linear dine, was linked to proteins of various molecular weights.
Up to 95% of the pentosidine was associated with10,000correlation documented between the zeta potential and
the binding capacity (expressed as mg/cm2) of the three molecular weight proteins,1% with10,000 molecular
weight proteins, and1% was free. These authors docu-non-modified membranes (AN69, PMMA, and PS) for
both proteins illustrates the crucial role of electrical mented the selective removal of free and low molecular
weight bound pentosidine with reused PS membranes,charge interactions between membrane and blood pro-
teins. The demonstration that the acidic (pH 5.1) gly- whereas the concentration of 10,000 molecular weight
AGE-modified proteins did not change significantly.cated 2m binding was less than that of the native, less
acidic, 2m (pH 5.7) supports this hypothesis [37]. Similar results were also obtained in hemodialyzed dia-
betic patients, where postdialysis AGEs levels decreasedThe role of membrane electronegativity was tested
using a unique modification of the AN69 membrane, significantly with the high-flux PS membrane but not
with low permeability conventional membranes [36, 38].whose cationic charges were neutralized by the polyanio-
nic compound PEI. Native 2m mass transfer was similar In contrast to hemodialysis, patients on peritoneal dial-
ysis had lower but still elevated steady-state AGE levels.through AN69 and AN69-PEI membranes, as was the
fraction of native 2m binding to the membrane. How- Whatever the dialysis technique, it has been suggested
that AGEs are products of the combined process ofever, the kinetic pattern of glycated 2m filtration also
was similar for both membranes but delayed when com- glycation and oxidation, since there is a good evidence
of a sustained oxidative stress in chronic uremia [39, 40].pared with native 2m, indicating that decreasing mem-
brane surface electronegativity by PEI did not change In conclusion, among the factors that govern the in
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is modified with imidazolone, a novel advanced glycation end prod-vitro filtration of native and glycated 2m through highly uct, in dialysis-related amyloidosis. Kidney Int 51:187–194, 1997
permeable dialysis membranes, we have documented 12. Brownlee M, Cerami A, Vlassara H: Advanced glycosylation
end products in tissue and the biochemical basis of diabetic compli-that changes in 2m molecular weight and electrical
cations. N Engl J Med 318:1315–1321, 1988charges rather than dialysis membrane surface electric
13. Makita Z, Bucala R, Rayfield EJ, et al: Reactive glycosylation
potential must be taken into account. Glycated 2m is end products in diabetic uremia and treatment of renal failure.
Lancet 343:1519–1522, 1994more acidic and has a higher molecular weight than na-
14. Friedlander MA, Wu YC, Schulak JA, et al: Influence of dialysistive 2m, and consequently crosses both charged and modality on plasma and tissue concentration of pentosidine in
noncharged membranes less well. Decreasing the elec- patients with end-stage renal disease. Am J Kidney Dis 25:445–451,
1995tronegativity of the AN69 membrane surface demon-
15. Miyata T, Ueda Y, Shinzato T, et al: Accumulation of albumin-strated that these physical modifications do not alter its
linked and free-form pentosidine in the circulation of uremic pa-
binding capacity for both native and glycated 2m. This tients with end-stage renal failure: Renal implication in the patho-
physiology of pentosidine. J Am Soc Nephrol 7:1198–1206, 1996paradoxal result could be due to the superficial effect of
16. Chanard J, Bindi P, Lavaud S, et al: Carpal tunnel syndrome andPEI, which does not neutralize the negatively charged
type of dialysis membrane. Br Med J 298:867–868, 1989
sulfonates of the copolymer core that remain unaltered 17. Van Ypersele de Strihou C, Jadoul M, Malghem J, et al: Effect
of dialysis membrane and patient’s age and signs of dialysis-relatedin the bulk of the AN69 gel, as it has been observed
amyloidosis. Kidney Int 39:1012–1019, 1991recently in the removal of small molecular weight pro- 18. Miura Y, Ishiyama T, Inomata A, et al: Radioluscent bone cyst
teins, such as cytochrome c and lysozyme [41, 42]. Al- and the type of dialysis membrane in patients undergoing long-
term hemodialysis. Nephron 60:268–273, 1992though these results were obtained in vitro, they may be
19. Vincent C, Chanard J, Caudwell V, et al: Kinetics of 125I-2-useful for designing clinical protocols focusing on the microglobulin turnover in dialyzed patients. Kidney Int 42:1434–
prevention of dialysis amyloidosis. 1443, 1992
20. Chanard J, Toupance O, Gillery P, et al: Evaluation of protein
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